title: Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468.
authors.forename: R
authors.initials: R
authors.lastname: Kapoon
authors.forename: Z
authors.initials: Z
authors.lastname: Pirtosek
authors.forename: J P
authors.initials: JP
authors.lastname: Frankel
authors.forename: G M
authors.initials: GM
authors.lastname: Stern
authors.forename: A J
authors.initials: AJ
authors.lastname: Lees
authors.forename: J M
authors.initials: JM
authors.lastname: Bottomley
authors.forename: N S
authors.initials: NS
authors.lastname: Haran
mesh_terms: D015259:Dopamine Agents / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects
chemical_list: D015259:Dopamine Agents; D007211:Indoles; C046649:ropinirole; D007980:Levodopa